Zymeworks Inc (ZYME)

Zymeworks (ZYME) Stock Price & Analysis


ZYME Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.11 - $10.80
Previous Close$8.73
Average Volume (3M)527.82K
Market Cap
Enterprise Value$101.83M
Total Cash (Recent Filing)$492.23M
Total Debt (Recent Filing)$28.11M
Price to Earnings (P/E)3.4
Aug 02, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.58
Shares Outstanding57,892,785
10 Day Avg. Volume409,042
30 Day Avg. Volume527,820
Standard Deviation0.17
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda0.71
Price Target Upside51.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Zymeworks Inc’s price range in the past 12 months?
Zymeworks Inc lowest stock price was $4.11 and its highest was $10.80 in the past 12 months.
    What is Zymeworks Inc’s market cap?
    Currently, no data Available
    When is Zymeworks Inc’s upcoming earnings report date?
    Zymeworks Inc’s upcoming earnings report date is Aug 02, 2023 which is in 54 days.
      How were Zymeworks Inc’s earnings last quarter?
      Zymeworks Inc released its earnings results on May 08, 2023. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.536 by $0.166.
        Is Zymeworks Inc overvalued?
        According to Wall Street analysts Zymeworks Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Zymeworks Inc pay dividends?
          Zymeworks Inc does not currently pay dividends.
          What is Zymeworks Inc’s EPS estimate?
          Zymeworks Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Zymeworks Inc have?
          Zymeworks Inc has 64,171,280 shares outstanding.
            What happened to Zymeworks Inc’s price movement after its last earnings report?
            Zymeworks Inc reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.536. Following the earnings report the stock price went up 12.785%.
              Which hedge fund is a major shareholder of Zymeworks Inc?
              Among the largest hedge funds holding Zymeworks Inc’s share is Perceptive Advisors LLC. It holds Zymeworks Inc’s shares valued at 31M.


                Zymeworks Stock Smart Score

                The Zymeworks stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Zymeworks Inc

                Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.


                Top 5 ETFs holding ZYME

                Market Value
                Smart Score
                Picton Mahoney Fortified Long Short Alternative Fund Trust Units
                Fidelity MSCI Health Care Index ETF
                Dimensional U.S. Equity ETF
                Picton Mahoney Fortified Active Extension Alternative Fund ETF
                Up to five ETFs with an Outperform Smart Score that hold ZYME. The ETFs are listed according to market value of ZYME within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Fate Therapeutics
                Crispr Therapeutics AG

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis